Building A Reproducible Single-cell Experimental Workflow To Capture Tumour Drug Persistence

Name: Building A Reproducible Single-cell Experimental Workflow To Capture Tumour Drug Persistence
Start: 2021-10-30
End: 2026-06-30
Location: STICHTING ONCODE INSTITUTE

STICHTING ONCODE INSTITUTE Netherlands has Released a tender for Building A Reproducible Single-cell Experimental Workflow To Capture Tumour Drug Persistence in Laboratory Equipment and Services. The tender was released on Jan 01, 1970.

Country - Netherlands

Summary - Building A Reproducible Single-cell Experimental Workflow To Capture Tumour Drug Persistence

Deadline - Jun 30, 2026

MT reference number - 10363952

Product classification -

Organization Details:

Address - Netherlands

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 10363952

Document Type - Tender Notices

Notice Details and Documents:

Description - Grant agreement ID: 101007937Start date 1 July 2021End date 30 June 2026Overall budget € 14 031 380 ObjectiveIt is the ambition of PRESIST-SEQ to provide a new gold standard in single-cell experimental workflows the cancer research community by dev eloping best practices, standard operating procedures (SOPs), and high-quality FAIR data, with the ultimate aim to empower them to unravel therapeutic resistance. Such, that the community can identify urgently needed markers to predict, prevent, and target tumour resistance. Cancer takes 9.6 million lives each year, 90% of which result from untreatable metastatic relapse occurring after initially (seemingly) effective treatment. Therapeutic resis

Mt Ref Id - 10363952

Deadline - Jun 30, 2026

View more tenders for

Netherlands Tenders

Most Searched